Real-time enrollment status for this pulmonary fibrosis clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT05785624 |
| Recruiting Status | Terminated |
| Condition | Pulmonary Fibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 320 participants |
| Active Locations | 29 sites in the US |
| Sponsor | Genentech, Inc. |
| Last Updated on CT.gov | February 9, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT05785624 is currently terminated participants. This clinical trial study for pulmonary fibrosis is not currently accepting new participants at 29 locations across the United States. The study is sponsored by Genentech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05785624 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05785624 was last updated 3 weeks ago (February 9, 2026). HelloStudys verifies this status automatically.